AbCellera Biologics (ABCL) Earnings Date & Reports
A.I. Advisor
published Earnings
ABCL is expected to report earnings to rise 13.09% to -12 cents per share on November 05
Q3'24
Est.
$-0.12
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.02
Q4'23
Missed
by $0.05
Q3'23
Beat
by $0.02
The last earnings report on August 06 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 2.19M shares outstanding, the current market capitalization sits at 804.44M.